Philippe Gervais
Overview
Explore the profile of Philippe Gervais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sigaut S, Tardivon C, Jacquens A, Bottlaender M, Gervais P, Habert M, et al.
BMJ Open
. 2024 Dec;
14(12):e091441.
PMID: 39740941
Introduction: Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. Treatments for TBI patients are limited and none has been shown to provide prolonged...
2.
Lagarde J, Olivieri P, Tonietto M, Noiray C, Lehericy S, Valabregue R, et al.
Alzheimers Res Ther
. 2024 May;
16(1):97.
PMID: 38702802
Background: The locus coeruleus (LC) and the nucleus basalis of Meynert (NBM) are altered in early stages of Alzheimer's disease (AD). Little is known about LC and NBM alteration in...
3.
Quigley N, dAmours L, Gervais P, Dion G
Open Forum Infect Dis
. 2024 Jan;
11(1):ofad639.
PMID: 38274551
Background: pneumonia (PJP) remains a significant threat in immunocompromised cases. Recent data on epidemiology and risk factors for PJP in non-HIV cases are scarce, and guidelines on appropriate prophylaxis are...
4.
Leroy C, Goutal S, Breuil L, Gervais P, Cherkaoui H, Ciuciu P, et al.
Eur J Nucl Med Mol Imaging
. 2023 May;
50(10):3153-3154.
PMID: 37148295
No abstract available.
5.
Lagarde J, Olivieri P, Tonietto M, Rodrigo S, Gervais P, Caille F, et al.
Alzheimers Res Ther
. 2023 May;
15(1):91.
PMID: 37138309
Background: Monitoring the progression of Tau pathology makes it possible to study the clinical diversity of Alzheimer's disease. In this 2-year longitudinal PET study, we aimed to determine the progression...
6.
Hamzaoui M, Garcia J, Boffa G, Lazzarotto A, Absinta M, Ricigliano V, et al.
Ann Neurol
. 2023 Apr;
94(2):366-383.
PMID: 37039158
Objective: To determine the prognostic value of persisting neuroinflammation in multiple sclerosis (MS) lesions, we developed a 18 kDa-translocator-protein-positron emission tomography (PET) -based classification of each lesion according to innate...
7.
Han H, Wang J, Birnie D, Alings M, Philippon F, Parkash R, et al.
JAMA Cardiol
. 2023 Apr;
8(5):484-491.
PMID: 37017943
Importance: Cardiac implantable electronic device (CIED) infection is a potentially devastating complication with an estimated 12-month mortality of 15% to 30%. The association of the extent (localized or systemic) and...
8.
Marquis B, Demonmerot F, Richou C, Thiefin G, Millon L, Wallon M, et al.
Parasite
. 2023 Apr;
30:9.
PMID: 37010450
Alveolar echinococcosis (AE) is a severe parasitic infection caused by the ingestion of Echinococcus multilocularis eggs. While higher incidence and faster evolution have been reported in immunosuppressed patients, no studies...
9.
Quigley N, Couture C, Gervais P, Maltais F
Chest
. 2023 Mar;
163(3):e111-e114.
PMID: 36894264
A 37-year-old man attended a medical clinic at the confluence of the Appalachian and the St. Lawrence Valley after 2 weeks of coughing greenish sputum and progressive dyspnea on exertion....
10.
Marie S, Breuil L, Chalampalakis Z, Becquemont L, Verstuyft C, Lecoq A, et al.
Biomed Pharmacother
. 2022 Nov;
156:113994.
PMID: 36411655
Organic Anion-Transporting Polypeptides (OATPs) are known to control the liver uptake of many drugs. Non-hepatic expression of OATPs has been reported although functional importance for whole-body pharmacokinetics (WBPK) remains unknown....